EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Erythrocyte-Derived microRNAs: Emerging Players in Cardiovascular and Metabolic Disease

Eftychia Kontidou, Aida Collado, John Pernow iD, Zhichao Zhou iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2023-05 · 43 (5) · 628-636

DOI: 10.1161/atvbaha.123.319027 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2023-05. Verfasst von Eftychia Kontidou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine Solna, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden (E.K., A.C., J.P., Z.Z…. Hauptthemen laut MEDLINE: MicroRNAs, Diabetes Mellitus, Type 2, COVID-19, Cardiovascular Diseases. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 93 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent studies have demonstrated a novel function of red blood cells (RBCs) beyond their classical role as gas transporters, that is, RBCs undergo functional alterations in cardiovascular and metabolic disease, and RBC dysfunction is associated with hypertension and the development of cardiovascular injury in type 2 diabetes, heart failure, preeclampsia, familial hypercholesterolemia/dyslipidemia, and COVID-19. The underlying mechanisms include decreased nitric oxide bioavailability, increased arginase activity, and reactive oxygen species formation. Of interest, RBCs contain diverse and abundant micro (mi)RNAs. miRNA expression pattern in RBCs reflects the expression in the whole blood, serum, and plasma. miRNA levels in RBCs have been found to be altered in various cardiovascular and metabolic diseases, which contributes to the development of cardiovascular complications. Evidence has shown that RBC-derived miRNAs interact with the cardiovascular system via extracellular vesicles and argonaute RISC catalytic component 2 as carriers. Alteration of RBC-to-vascular communication via miRNAs may serve as potential disease mechanism for vascular complications. The present review summarizes RBCs and their released miRNAs as potential mediators of cardiovascular injury. We further focus on the possible mechanisms by which RBC-derived miRNAs regulate cardiovascular function. A better understanding of the function of RBC-derived miRNAs will increase insights into the disease mechanism and potential targets for the treatment of cardiovascular complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsDiabetes Mellitus, Type 2COVID-19Cardiovascular DiseasesFemalePregnancyHumansErythrocytesHeart

Stichwörter der Autor:innen

cardiovascular diseasediabetesextracellular vesiclemetabolic diseasemiRNAred blood cell

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • Division of Cardiology, Department of Medicine Solna, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden (E.K., A.C., J.P., Z.Z.).
  • Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden (J.P.).

ORCID-Profile: John Pernow, Zhichao Zhou

Zitieren

APA

Kontidou, E., Collado, A., Pernow, J., & Zhou, Z. (2023). Erythrocyte-Derived microRNAs: Emerging Players in Cardiovascular and Metabolic Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 43(5), 628-636. https://doi.org/10.1161/atvbaha.123.319027

Vancouver

Kontidou E, Collado A, Pernow J, Zhou Z. Erythrocyte-Derived microRNAs: Emerging Players in Cardiovascular and Metabolic Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023;43(5):628-636. doi:10.1161/atvbaha.123.319027

BibTeX
@article{Kontidou2023,
  author = {Kontidou, Eftychia and Collado, Aida and Pernow, John and Zhou, Zhichao},
  title = {Erythrocyte-Derived microRNAs: Emerging Players in Cardiovascular and Metabolic Disease},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2023},
  volume = {43},
  number = {5},
  pages = {628--636},
  doi = {10.1161/atvbaha.123.319027}
}
Kostenlos starten →